Updated:
Xintaige Asset Management
Wang Hongxin established Xintaige Asset Management in Beijing in 2008, positioning the firm as an early-stage investor in China's technology supply chain.
Xintaige Asset Management
Wang Hongxin established Xintaige Asset Management in Beijing in 2008, positioning the firm as an early-stage investor in China's technology supply chain. Unlike the consumer-internet funds that dominated Chinese venture capital during the 2010s, Xintaige targeted enterprise software, industrial automation, and deep-tech startups born out of Chinese research institutions. The firm's founding thesis held that China's industrial upgrading would produce a generation of B2B technology champions — a wager that shaped its entire portfolio construction. Xintaige deploys capital primarily through direct equity investments at the seed and pre-IPO stages, bridging the gap between academic spinouts and public-market readiness. Its strategy spans enterprise software, AI/ML, industrial technology, and digital health. Known portfolio holdings include Yuanxin Technology, a health-tech platform, and Shenzhen New Industries Biomedical Engineering, a diagnostic-equipment manufacturer that listed on the Shenzhen Stock Exchange (per public record). Geographically, the firm concentrates on Greater China, with deal flow sourced from Beijing, Shanghai, and Shenzhen's technology corridors. Operational scale remains opaque — Xintaige does not publicly disclose assets under management or headcount. The firm maintains a single office in Beijing. Adjacent vehicles are undocumented. A regulatory filing from 2024 confirms Xintaige continues active fundraising and investment activity in China's domestic venture market, consistent with its long-standing posture as a low-profile institutional player (per public record, 2024). The firm's structural differentiator is its reliance on China's formal research infrastructure for deal origination — a model distinct from the network-driven approach of Western-style venture capital. Xintaige maintains ties to university labs, state-backed incubators, and industrial research consortia that give it early visibility into technology transfer projects before they attract broader venture attention. This institutional pipeline, rather than founder-networking events or demo days, defines its investment cadence.
General information
Firm type
Private Equity
Year founded
2008
AUM
Undisclosed
Location
Region
Asia
Country
China
City
Beijing
Corporate office
Beijing, China
Principals
Wang Hongxin
Founder
Sector focus
Frequently asked questions
Who runs investment decisions at Xintaige Asset Management?
Founder Wang Hongxin leads investment decisions. Public records identify Wang as the firm's central decision-maker since its 2008 founding. Xintaige's organizational structure is not publicly disclosed, so the extent of supporting investment staff or formal committee processes remains undocumented.
What investment stages does Xintaige Asset Management target?
Xintaige concentrates on seed-stage and pre-IPO investments, according to public filings. This dual-end focus allows the firm to access technology at its earliest institutional entry point and to capture late-stage value before public listing. The firm does not appear to participate in Series A through Series C rounds as a standard practice.
Which sectors does Xintaige Asset Management explicitly invest in?
Xintaige invests in enterprise software, artificial intelligence and machine learning, industrial technology, and digital health. Publicly documented portfolio companies include Yuanxin Technology, a health-tech platform, and Shenzhen New Industries Biomedical Engineering, a diagnostic equipment maker. The firm does not target consumer internet, e-commerce, or real estate.
How does Xintaige Asset Management source its deals?
Xintaige sources deals through China's formal research infrastructure — university labs, state-backed technology incubators, and industrial research consortia. This institutional pipeline gives the firm early visibility into technology transfer projects before they appear on traditional venture-capital radars. The approach contrasts with network-based or auction-driven deal origination common among peer firms.
Does Xintaige Asset Management disclose its assets under management?
No. Xintaige does not publicly disclose assets under management, total deployment, or fund-level performance. The firm operates with the opacity typical of domestic Chinese private equity managers that do not market to international institutional LPs.
What is Xintaige Asset Management's geographic focus?
Xintaige concentrates on Greater China, with deal flow originating from Beijing, Shanghai, and Shenzhen. The firm's investment mandate does not publicly include cross-border investments or offshore structures, though some portfolio companies may eventually pursue overseas listings.
What is the known investment history of Xintaige Asset Management?
Xintaige has backed companies including Yuanxin Technology, a digital-health platform, and Shenzhen New Industries Biomedical Engineering, which subsequently listed on the Shenzhen Stock Exchange. Beyond these publicly identifiable names, the firm's broader portfolio and exit track record are not systematically disclosed in English-language sources.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: